EKG Fundamental Analysis - CARDIOCOMM SOLUTIONS INC

Fundamental Rating

EKG gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 9 industry peers in the Health Care Technology industry. Both the profitability and financial health of EKG have multiple concerns. EKG has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year EKG has reported negative net income.

In the past year EKG has reported a negative cash flow from operations.

In the past 5 years EKG reported 4 times negative net income.

The reported operating cash flow has been mixed in the past 5 years: EKG reported negative operating cash flow in multiple years.

1.2 Ratios

EKG's Return On Assets of -89.02% is on the low side compared to the rest of the industry. EKG is outperformed by 66.67% of its industry peers.

		Industry Rank	Sector Rank
ROA	-89.02%
ROE	N/A
ROIC	N/A

ROA(3y)-39.46%

ROA(5y)-27.19%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 95.03%, EKG belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.

EKG's Gross Margin has improved in the last couple of years.

EKG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	95.03%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y2.02%

GM growth 5Y5.8%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

EKG does not have a ROIC to compare to the WACC, probably because it is not profitable.

EKG has more shares outstanding than it did 1 year ago.

The number of shares outstanding for EKG has been increased compared to 5 years ago.

EKG has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -200.55, we must say that EKG is in the distress zone and has some risk of bankruptcy.

With a Altman-Z score value of -200.55, EKG is not doing good in the industry: 88.89% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-200.55

ROIC/WACCN/A

WACC8.1%

2.3 Liquidity

A Current Ratio of 0.34 indicates that EKG may have some problems paying its short term obligations.

Looking at the Current ratio, with a value of 0.34, EKG is doing worse than 66.67% of the companies in the same industry.

EKG has a Quick Ratio of 0.34. This is a bad value and indicates that EKG is not financially healthy enough and could expect problems in meeting its short term obligations.

The Quick ratio of EKG (0.28) is worse than 66.67% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.34
Quick Ratio	0.28

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

EKG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -200.00%.

The Revenue for EKG has decreased by -30.33% in the past year. This is quite bad

The Revenue has been decreasing by -9.65% on average over the past years.

EPS 1Y (TTM)-200%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-133.33%

Revenue 1Y (TTM)-30.33%

Revenue growth 3Y-8.28%

Revenue growth 5Y-9.65%

Sales Q2Q%-14.6%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for EKG!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CARDIOCOMM SOLUTIONS INC

TSX-V:EKG (9/11/2025, 7:00:00 PM)

0.005

0 (-50%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Technology

Earnings (Last)09-01 2025-09-01

Earnings (Next)11-27 2025-11-27

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners26.08%

Ins Owner ChangeN/A

Market Cap986.20K

Analysts0

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	1.87
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)0

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0

FCFYN/A

OCF(TTM)0

OCFYN/A

SpS0

BVpS0

TBVpS0

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-89.02%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	95.03%
FCFM	N/A

ROA(3y)-39.46%

ROA(5y)-27.19%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y2.02%

GM growth 5Y5.8%

F-Score4

Asset Turnover2.41

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	17.24%
Cap/Sales	0.95%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.34
Quick Ratio	0.28
Altman-Z	-200.55

F-Score4

WACC8.1%

ROIC/WACCN/A

Cap/Depr(3y)20.33%

Cap/Depr(5y)27.18%

Cap/Sales(3y)0.73%

Cap/Sales(5y)0.9%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-200%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-133.33%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-30.33%

Revenue growth 3Y-8.28%

Revenue growth 5Y-9.65%

Sales Q2Q%-14.6%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-40.24%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-106.24%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-104.62%

OCF growth 3YN/A

OCF growth 5YN/A

CARDIOCOMM SOLUTIONS INC (EKG.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens